Remdesivir Reduces Mortality in Hemato-Oncology Patients with COVID-19

Remdesivir Reduces Mortality in Hemato-Oncology Patients with COVID-19

Bogusz Jan Aksak-Wąs,1 Daniel Chober,1 Karol Serwin,1 Kaja Scheibe,1 Jolanta Niścigorska-Olsen,2 Anna Niedźwiedź,3 Monika Dobrowolska,3 Katarzyna Żybul,4 Marta Kubacka,4 Agnieszka Zimoń,5 Ewa Hołda,4 Joanna Mieży&...

Full description

Bibliographic Details
Main Authors: Aksak-Wąs BJ, Chober D, Serwin K, Scheibe K, Niścigorska-Olsen J, Niedźwiedź A, Dobrowolska M, Żybul K, Kubacka M, Zimoń A, Hołda E, Mieżyńska-Kurtycz J, Gryczman M, Jamro G, Szakoła P, Parczewski M
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Journal of Inflammation Research
Subjects:
covid-19
sars-cov-2
remdesivir
mortality
hemato-oncology
Online Access:https://www.dovepress.com/remdesivir-reduces-mortality-in-hemato-oncology-patients-with-covid-19-peer-reviewed-fulltext-article-JIR

Internet

https://www.dovepress.com/remdesivir-reduces-mortality-in-hemato-oncology-patients-with-covid-19-peer-reviewed-fulltext-article-JIR

Similar Items